Breast Cancer Risk Management
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference51 articles.
1. Overview of the main outcomes in breast cancer prevention trials;Cuzick;Lancet,2003
2. Patient reluctance toward tamoxifen use for breast cancer primary prevention;Port;Ann Surg Oncol,2001
3. Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump;Taylor;Ann Fam Med,2005
4. Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors;Bober;J Clin Oncol,2004
5. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually;Gail;J Natl Cancer Inst,1989
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer;Oncology Letters;2017-06-02
2. Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake;ecancermedicalscience;2015-11-24
3. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo;Molecules;2015-07-09
4. Breast Disease;Swanson's Family Medicine Review: A Problem-Oriented Approach;2013
5. Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010;Breast Cancer Research and Treatment;2012-05-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3